Article
Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
Cancer genetics and cytogenetics - 15 Apr 2000
Hung G, Faudoa R, Baser M E, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D
Abstract excerpt
We used a novel RNase cleavage assay (NIRCA) to screen for neurofibromatosis 2 (NF2) mutations in NF2 schwannomas. Mutations were found in tumors in 16 of 20 patients. Eleven patients (55%) had loss of heterozygosity or loss of one allele, indicating that the mutation was a germ-line mutation. The phenotypes of these patients were consistent with previous NF2 genotype-phenotype correlation studies: patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
